Albazee Ebraheem, Hussain Salman, Abduljabbar Aysha, AlHajri Maisem Tariq, Alsakka Mahmoud Abdelaziz, Abu-Zaid Ahmed
Kuwait Institute for Medical Specializations (KIMS), Kuwait City, Kuwait.
RCSI University of Medicine and Health Sciences, Dublin, Ireland.
Indian J Otolaryngol Head Neck Surg. 2023 Dec;75(4):3621-3627. doi: 10.1007/s12070-023-04022-7. Epub 2023 Jul 12.
This systematic review and meta-analysis of randomized controlled trials (RCTs) aimed to comprehensively evaluate the efficacy of coblation versus harmonic scalpel methods among patients undergoing tonsillectomy.
PubMed, Cochrane Central Register of Controlled Trials, Scopus, Web of Science, and Google Scholar databases were systematically screened from inception until October 2022. The outcomes were summarized as risk ratio (RR) or mean difference/standardized mean difference (MD/SMD) with 95% confidence interval (CI) in a random-effects model.
Six RCTs were analyzed, encompassing a sum of 461 patients (harmonic scalpel = 233 patients and coblation = 228 patients). The overall quality assessment was low risk of bias in two RCTs, some concerns of bias in three RCTs, and high risk of bias in one RCT. There was no significant difference between harmonic scalpel and coblation groups regarding the mean operative time (n = 6 RCTs, MD=-7.45 min, 95% CI [-15.26, 0.01], p = 0.06) mean intraoperative blood loss (n = 5 RCTs, MD=-36.03 ml, 95% CI [-77.46, 5.41], p = 0.09), and rate of postoperative hemorrhage (n = 5 RCTs, RR = 0.59, 95% CI [0.25, 1.39], p = 0.23). The overall postoperative pain score was significantly reduced in favor of the coblation group compared with the harmonic scalpel group (n = 5 RCTs, MD = 0.40, 95% CI [0.10, 0.69], p = 0.009)".
The harmonic scalpel and coblation techniques share equal efficacy among patients undergoing tonsillectomy. The reduction in postoperative pain score provided by the coblation method is not clinically meaningful in clinical practice. Additional RCTs are needed to consolidate the power and quality of the presented evidence.
The online version contains supplementary material available at 10.1007/s12070-023-04022-7.
本随机对照试验(RCT)的系统评价和荟萃分析旨在全面评估扁桃体切除术患者中,低温等离子刀与超声刀方法的疗效。
从数据库创建之初至2022年10月,对PubMed、Cochrane对照试验中心注册库、Scopus、科学引文索引和谷歌学术数据库进行系统筛选。结局指标采用随机效应模型,汇总为风险比(RR)或均差/标准化均差(MD/SMD)及95%置信区间(CI)。
分析了6项RCT,共纳入461例患者(超声刀组 = 233例患者,低温等离子刀组 = 228例患者)。总体质量评估显示,2项RCT偏倚风险低,3项RCT存在一些偏倚问题,1项RCT偏倚风险高。超声刀组和低温等离子刀组在平均手术时间(n = 6项RCT,MD = -7.45分钟,95% CI [-15.26, 0.01],p = 0.06)、平均术中失血量(n = 5项RCT,MD = -36.03毫升,95% CI [-77.46, 5.41],p = 0.09)和术后出血率(n = 5项RCT,RR = 0.59,95% CI [0.25, 1.39],p = 0.23)方面无显著差异。与超声刀组相比,低温等离子刀组术后总体疼痛评分显著降低(n = 5项RCT,MD = 0.40,95% CI [0.10, 0.69],p = 0.009)。
在扁桃体切除术患者中,超声刀和低温等离子刀技术疗效相当。低温等离子刀方法降低的术后疼痛评分在临床实践中并无临床意义。需要更多RCT来巩固现有证据的效力和质量。
在线版本包含可在10.1007/s12070-023-04022-7获取的补充材料。